June 9, 2020 06:29 AM EDT
Deals
China
Cell/Gene Tx

Lil­ly, In­cyte-al­lied Chi­nese drug­mak­er In­novent bags Roche as part­ner in deal that could yield bil­lions

Natalie Grover

Reporter

Chi­na’s bi­o­log­ic pow­er­house In­novent has snagged an­oth­er il­lus­tri­ous part­ner: Roche.
The com­pa­ny — which made its pub­lic de­but on Hong Kong Stock Ex­change in 2018 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times